The prognostic importance of the negative regulators of ferroptosis, GPX4 and HSPB1, in patients with colorectal cancer

  • 0Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.

|

|

Summary

This summary is machine-generated.

Negative regulators of ferroptosis, specifically glutathione peroxidase 4 (GPX4) and heat shock protein β-1 (HSPB1), are poor prognostic markers in colorectal cancer (CRC). High expression of GPX4 and HSPB1 predicts worse survival and recurrence in CRC patients.

Area Of Science

  • Biochemistry
  • Oncology
  • Molecular Biology

Background

  • The prognostic significance of ferroptosis regulators in colorectal cancer (CRC) remains incompletely understood.
  • Ferroptosis, a regulated form of cell death, is implicated in cancer progression and treatment response.

Purpose Of The Study

  • To systematically identify and validate negative regulators of ferroptosis as prognostic biomarkers in colorectal cancer.
  • To investigate the role of identified regulators in chemoresistance.

Main Methods

  • <i>In silico</i> analysis of The Cancer Genome Atlas (TCGA) data for ferroptosis regulators.
  • Clinical validation using immunohistochemistry on CRC patient samples (n=166).
  • <i>In vitro</i> experiments with small interfering RNAs (siRNAs) in CRC cell lines.

Main Results

  • <i>In silico</i> analysis identified GPX4 and HSPB1 as key candidate negative regulators.
  • High GPX4 and HSPB1 expression correlated with significantly worse overall survival (OS) and recurrence-free survival (RFS) in CRC patients (P<0.01).
  • GPX4 and HSPB1 knockdown attenuated the cytotoxic effect of 5-fluorouracil chemotherapy in CRC cell lines.

Conclusions

  • Glutathione peroxidase 4 (GPX4) and heat shock protein β-1 (HSPB1) are significant prognostic and recurrence-predictive biomarkers in colorectal cancer.
  • GPX4 and HSPB1 may play a role in chemoresistance, suggesting potential therapeutic targets.